Does Red Light Therapy Help POTS?

What Does Red Light Therapy Target?

Red light therapy, also called photobiomodulation or low-level light therapy, shines red or near-infrared light on the skin or head at low power. The best-known explanation sits inside the cell. A review of the proposed mechanisms calls it "the leading hypothesis": the light frees nitric oxide from an enzyme in the mitochondria, the cell's power plants, so the enzyme can move electrons faster and the cell makes more ATP, its energy currency. A second hypothesis is that light opens light-sensitive channels in the cell membrane and lets calcium in (de Freitas, 2016).

Both are still hypotheses. An earlier review of how cells absorb this light says the mechanism "still remains to be completed" and needs more research (Passarella, 2014). So when a device seller describes exactly what red light does inside you, they're describing a leading idea that hasn't been settled.

In an fMRI study in humans, with no POTS patients, the abstract reports that the brain's blood-flow response to pulsed light on the head "is not restrained to the site of irradiation, but quickly spreads to distal sites," and the authors add that the right dose still hasn't been worked out for most brain stimulation methods (Van Lankveld, 2026). In a sham-controlled trial in 98 healthy young volunteers, the abstract reports that near-infrared light on the head changed measures of vergence, how the 2 eyes turn in together (Trofimov, 2025). Both studies show that the brain responds, and neither shows that anyone felt better or functioned better.

How Does Red Light Fit a Brain Blood-Flow Problem?

In our team's view, the trouble upright in POTS sits with how the brain controls its own blood flow when gravity pulls blood toward your feet. The fast heart rate is a rescue for brain blood flow: when standing pulls blood away from your head and the systems that should hold brain blood flow steady fall behind, the heart speeds up to make up the difference. POTS is that rescue succeeding, and orthostatic hypotension, where blood pressure falls on standing, is the rescue failing. Red light's leading mechanism works at the level of tissue energy, and our team hasn't seen a source showing it changes the brain's control of blood flow upright.

The 2 studies closest to the autonomic nervous system found little. In a double-blind phase with 12 people, 6 of them with complex regional pain syndrome, light from a polarized visible and near-infrared lamp aimed at the stellate ganglion, a cluster of sympathetic nerves at the base of the neck, produced what the abstract reports as "no statistically significant changes in autonomic function" (Basford, 2003). In 34 physically active adults, light over the vagus nerve induced what the abstract calls "minimal acute modulation of autonomic complexity," measured from heart rate variability (Pereira, 2026). Neither study included anyone with POTS, so neither settles the question, and neither gives a reason to expect red light to steady the heart rate on standing.

What Does the Research Show for POTS and Dysautonomia?

We found no published trial, case series or pilot of red or near-infrared light in POTS, orthostatic intolerance or dysautonomia. Anyone telling you research shows red light helps POTS is pointing at studies of something else.

The wider field is large and weak. An umbrella review of 100 systematic reviews across clinical conditions found that 62 reached favorable conclusions, 34 were neutral or mixed and 4 were unclear. The abstract reports that 30% of those reviews rated low and 60% critically low in confidence, and the authors write that these patterns "do not establish treatment efficacy" (Song, 2026). The reviews covered mostly oral and dental conditions (53 of 100), musculoskeletal disorders (22), cancer-related complications (8) and wound and lymphatic conditions (8), and the highest share of favorable conclusions was for cancer-related complications such as mouth sores during treatment. None of those is autonomic disease.

The nearest trial to a POTS symptom is in post-COVID brain fog. In a double-blind, sham-controlled pilot, 43 adults used home intranasal and transcranial light for 8 weeks. The abstract reports that cognitive scores leaned toward the active device without reaching statistical significance (p = 0.088), while mobility favored the sham device (p = 0.007) and fatigue also favored sham. No serious adverse events occurred. The trial was funded by Vielight Inc., which makes the device, and every author was a Vielight employee, consultant or advisor. The authors concluded the device may help cognition, particularly in younger adults, and called for larger trials (Lim, 2026). An earlier open-label pilot with 7 people per group and no sham device reported better cognitive test scores (Bowen, 2023), but without a sham group it can't separate the light from expectation. Fog that's worse upright often comes from low brain blood flow, which our team explains in POTS brain fog.

Replay

Who Might Red Light Therapy Help?

In our team's experience, red light earns a place with 2 groups. The first is people who aren't mobile enough to get outside yet, or who don't do well in the sun because of how their body distributes blood flow. For them, our team uses red light to give the body's tissues a start, with the goal of getting them outside. The second is people who get little daylight, such as those in northern winters or those working indoor jobs, where our team uses red light in the dark months as a partial stand-in for the daylight they're missing.

Red light can be 1 input in a plan that's built around how your brain handles being upright. In 1 patient's case, which our team followed through the first 2 weeks of treatment, photobiomodulation went to her neck, head and brainstem alongside eye-movement and rotation work, neck mobilizations and exercise with oxygen (read her case). It's a single case, and it can't show what the light added on its own.

Who Could Red Light Therapy Hurt or Hold Back?

The biggest cost our team sees is red light standing in for a workup. People have gotten excited about red light in a way that isn't specifically useful, expecting that a device will fix 1 problem. In our team's view, the light gives your body more to work with, and it doesn't find or retrain whatever is driving your heart rate up when you stand.

Because of the dose curve above, more light can do less.

Safety data are thin. Of the 100 reviews in the umbrella review, 32 reported no adverse events, 11 reported at least 1 and 57 gave no adverse-event information at all, which the authors say precludes firm conclusions about safety (Song, 2026). In 1 cross-sectional study of children treated for nearsightedness with a single low-power red laser, the abstract reports no significant loss of the eye's cone cells or retinal blood vessel problems after 8 months (Yue, 2026). A case report describes retinal damage in a 12-year-old with nearsightedness after repeated low-level red-light laser exposure (Liu, 2023), so the eye data point both ways. Both involve red lasers used for nearsightedness, and neither says anything about home panels. The sources above don't cover skin conditions, light-sensitizing medicines, pregnancy or eye protection with home panels, so those are questions for your prescriber.

Where Does Red Light Fit in the Order of Care?

Our team works in a set order. First, find out what's driving the regulation problem: how your brain, balance system, breathing and blood vessels handle being upright. Second, spend time outdoors in daylight when you tolerate it, avoiding heat and sunburn. Third, use red light as a bridge when the plan calls for it, for the person who can't get outside yet or the winter with little daylight. We found no study of sun for POTS either, so this order is our team's view, and no trial has tested it.

Medications can ease POTS symptoms, and in our team's view they're a bridge with a ceiling: they help while you take them without retraining how your brain regulates blood flow. Starting, stopping or changing them is the prescriber's call. Our team's chiropractic neurologists don't prescribe, so we leave existing medications alone and work on the regulation underneath.

Red Light Therapy and POTS: FAQ